Skip to main content
Clinical Trials/JPRN-UMIN000023681
JPRN-UMIN000023681
Completed
N/A

Evaluation of efficiency and safety of dapagliflozin in treating of type 2 diabetes mellitus - Efficiency and safety of dapagliflozin

Juntendo University Urayasu Hospital0 sites30 target enrollmentAugust 20, 2016
Conditionstype 2 diabetes

Overview

Phase
N/A
Intervention
Not specified
Conditions
type 2 diabetes
Sponsor
Juntendo University Urayasu Hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 20, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Type 1 diabetes mellitus 2\.Diabetic ketoacidosis, diabetic coma, or before coma 3\.Sever infection, before and not long after surgery, or patients with sever trauma 4\.Left ventricular dysfunction (EF \< 50%) 5\.Sever liver dysfunction 6\.Past history of cerebral infarction, myocardial infarction, and sever heart failure 7\.Women suspected of pregnancy or pregnant 8\.Patients with a history of use SGLT2 inhibitors 9\.Patients who have repeated urinary tract infections 10\.Alchole intake excessive 11\.Inadequate patients judged by doctor

Outcomes

Primary Outcomes

Not specified

Similar Trials